Acotec Scientific Holdings Ltd

Detailed Description

Acotec Scientific Holdings Limited engages in the development of interventional medical devices in the fields of drug-coated balloons and peripheral percutaneous transluminal angioplasty balloon catheter primarily for the treatment of vascular diseases. Its products include AcoArt Orchid & Dhalia, which is under registration process in vascular surgery for superficial femoral artery and popliteal artery disease indications/applications; under clinical studies in nephrology for arteriovenous fistula stenosis and in neurology for vertebral atherosclerotic stenosis indications/applications; and under pre-clinical studies in andrology for vasculogenic erectile dysfunction indications/applications. The company's products also include AcoArt Tulip & Litos, which is under registration process in China and Europe, and under preclinical studies in the United States in vascular surgery for below-the-knee artery disease indications/applications; and in pre-clinical studies in andrology for vasculogenic erectile dysfunction indications/applications. It serves customers in China, Europe, the United States, India, and internationally. The company was founded in 2011 and is based in Beijing, China. Acotec Scientific Holdings Limited operates as a subsidiary of CA Medtech Investment (Cayman) Limited.